Showing results (201-210 of 274) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Cancer Immunology Research|April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeBridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
Human Genetics|April 15, 2016
Assessing the genetic architecture of epithelial ovarian cancer histological subtypesGabriel Cuellar-Partida, Yi Lu, Suzanne C Dixon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesNicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testingPaul D P Pharoah, Rachel T Palmieri, Susan J Ramus, et al.
Human Molecular Genetics|August 2, 2015
Shared genetics underlying epidemiological association between endometriosis and ovarian cancerYi Lu, Gabriel Cuellar-Partida, Jodie N Painter, et al.
Nature Genetics|September 21, 2010
Common variants at 19p13 are associated with susceptibility to ovarian cancerKelly L Bolton, Jonathan Tyrer, Honglin Song, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinomaEun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Nature Genetics|September 21, 2010
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24Ellen L Goode, Georgia Chenevix-Trench, Honglin Song, et al.
Pageof 28